SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2020-06-02 14:07
Tx date 2020-05-31
$KHRN
Khiron Life Sciences Corp.
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,225,000
+500,000 vol
$2.45 each
1,000,000
Filed 2020-06-02 14:04
Tx date 2020-05-31
$KHRN
Khiron Life Sciences Corp.
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-1,225,000
-500,000 vol
$2.45 each
1,000,000
Filed 2020-06-02 13:30
Tx date 2020-05-31
$KHRN
Khiron Life Sciences Corp.
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$61,250
+25,000 vol
$2.45 each
950,000
Filed 2020-06-02 13:25
Tx date 2020-05-31
$KHRN
Khiron Life Sciences Corp.
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights
$-61,250
-25,000 vol
$2.45 each
50,000
Filed 2020-05-25 14:42
Tx date 2020-05-23
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$33,375
+37,500 vol
$0.89 each
158,900
Filed 2020-05-25 14:41
Tx date 2020-05-23
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-37,500 vol
0
Filed 2020-05-25 14:36
Tx date 2020-05-23
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$122,375
+137,500 vol
$0.89 each
600,000
Filed 2020-05-25 14:34
Tx date 2020-05-23
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-137,500 vol
0
Filed 2020-04-13 16:47
Tx date 2020-03-19
$KHRN
Khiron Life Sciences Corp.
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-55,200
-150,000 vol
$0.368 each
693,500
Filed 2020-04-13 16:46
Tx date 2020-03-18
$KHRN
Khiron Life Sciences Corp.
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-49,822.50
-136,500 vol
$0.365 each
843,500
Filed 2020-04-13 16:45
Tx date 2020-03-16
$KHRN
Khiron Life Sciences Corp.
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-19,950
-50,000 vol
$0.399 each
980,000
Filed 2020-04-13 16:43
Tx date 2020-03-13
$KHRN
Khiron Life Sciences Corp.
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-122,745
-245,000 vol
$0.50 each
1,030,000
Filed 2020-02-21 10:42
Tx date 2020-02-19
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,200
+5,000 vol
$0.64 each
462,500
Filed 2020-02-14 10:37
Tx date 2020-02-14
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$32,000
+50,000 vol
$0.64 each
716,500
Filed 2020-02-13 11:51
Tx date 2020-02-13
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$3,250
+5,000 vol
$0.65 each
457,500
Filed 2020-02-07 17:19
Tx date 2020-02-07
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$21,945
+28,500 vol
$0.77 each
666,500
Filed 2020-02-07 17:19
Tx date 2020-02-07
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$51,100
+70,000 vol
$0.73 each
638,000
Filed 2020-02-06 11:41
Tx date 2020-02-05
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$4,000
+5,000 vol
$0.80 each
452,500
Filed 2020-02-03 10:14
Tx date 2020-01-19
$KHRN
Khiron Life Sciences Corp.
Perez Silveira, Maximiliano
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-95,040
-99,000 vol
$0.96 each
250,641
Filed 2020-01-07 15:59
Tx date 2019-12-31
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$15,300
+15,000 vol
$1.02 each
447,500
Filed 2019-12-17 12:35
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$33,375
+37,500 vol
$0.89 each
121,400
Filed 2019-12-17 12:33
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-37,500 vol
37,500
Filed 2019-12-17 12:31
Tx date 2019-05-31
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$66,750
+75,000 vol
$0.89 each
75,000
Filed 2019-12-17 12:30
Tx date 2019-05-31
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-75,000 vol
75,000
Filed 2019-12-17 12:27
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$122,375
+137,500 vol
$0.89 each
432,500
Filed 2019-12-17 12:25
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-137,500 vol
137,500
Filed 2019-12-17 12:22
Tx date 2019-05-31
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$244,750
+275,000 vol
$0.89 each
275,000
Filed 2019-12-17 12:21
Tx date 2019-05-31
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-275,000 vol
275,000
Filed 2019-12-10 20:58
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,406,250,000
+37,500 vol
$37,500 each
Filed 2019-12-10 20:55
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-37,500 vol
Filed 2019-12-10 16:51
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+137,500 vol
Filed 2019-12-10 16:49
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-137,500 vol
Filed 2019-12-16 16:09
Tx date 2019-12-13
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,650
+5,000 vol
$0.93 each
1,060,000
Filed 2019-12-16 16:08
Tx date 2019-12-11
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$4,600
+5,000 vol
$0.92 each
1,055,000
Filed 2019-12-11 11:02
Tx date 2019-12-06
$KHRN
Khiron Life Sciences Corp.
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$61,250
+25,000 vol
$2.45 each
925,000
Filed 2019-12-11 11:00
Tx date 2019-05-31
$KHRN
Khiron Life Sciences Corp.
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
900,000
Filed 2019-12-11 10:56
Tx date 2019-12-06
$KHRN
Khiron Life Sciences Corp.
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-25,000 vol
75,000
Filed 2019-12-11 10:47
Tx date 2019-12-06
$KHRN
Khiron Life Sciences Corp.
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,225,000
+500,000 vol
$2.45 each
500,000
Filed 2019-12-11 10:41
Tx date 2018-07-17
$KHRN
Khiron Life Sciences Corp.
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-12-11 10:38
Tx date 2019-12-06
$KHRN
Khiron Life Sciences Corp.
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-500,000 vol
1,500,000
Filed 2019-12-10 21:10
Tx date 2019-12-06
$KHRN
Khiron Life Sciences Corp.
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
57 - Exercise of rights
$61,250
+25,000 vol
$2.45 each
1,275,000
Filed 2019-12-10 21:08
Tx date 2019-12-06
$KHRN
Khiron Life Sciences Corp.
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-25,000 vol
75,000
Filed 2019-12-10 20:58
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights
$1,406,250,000
+37,500 vol
$37,500 each
46,400
Filed 2019-12-10 20:55
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-37,500 vol
112,500
Filed 2019-12-10 20:53
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
150,000
Filed 2019-12-10 16:51
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights

+137,500 vol
157,500
Filed 2019-12-10 16:49
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
57 - Exercise of rights

-137,500 vol
412,500
Filed 2019-12-10 16:37
Tx date 2018-05-23
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+550,000 vol
550,000
Filed 2019-12-10 16:24
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-29 14:49
Tx date 2019-11-27
$KHRN
Khiron Life Sciences Corp.
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options

+800,000 vol
800,000
Filed 2019-11-29 14:47
Tx date 2019-10-01
$KHRN
Khiron Life Sciences Corp.
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-29 14:47
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
56 - Grant of rights

+800,000 vol
800,000
Filed 2019-11-29 14:46
Tx date 2019-10-01
$KHRN
Khiron Life Sciences Corp.
Katterbach, Franziska Maximiliane Maria Therese
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-29 14:43
Tx date 2019-11-27
$KHRN
Khiron Life Sciences Corp.
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
50 - Grant of options

+800,000 vol
800,000
Filed 2019-11-29 14:40
Tx date 2019-10-01
$KHRN
Khiron Life Sciences Corp.
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-29 14:40
Tx date 2019-11-25
$KHRN
Khiron Life Sciences Corp.
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
56 - Grant of rights

+800,000 vol
800,000
Filed 2019-11-29 14:38
Tx date 2019-10-01
$KHRN
Khiron Life Sciences Corp.
Virk, Tejinder
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-11-12 16:26
Tx date 2019-11-04
$KHRN
Khiron Life Sciences Corp.
Rosati, Deborah
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
17,000
Filed 2019-08-30 11:25
Tx date 2019-08-28
$KHRN
Khiron Life Sciences Corp.
Maduri, Livia Margarita
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$1,400
+1,000 vol
$1.40 each
1,000
Filed 2019-08-30 11:24
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Maduri, Livia Margarita
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-30 11:17
Tx date 2019-08-28
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$12,905
+8,900 vol
$1.45 each
8,900
Filed 2019-08-30 11:15
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-30 11:10
Tx date 2019-08-28
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$28,200
+20,000 vol
$1.41 each
20,000
Filed 2019-08-30 11:07
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-08-30 11:04
Tx date 2019-08-28
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$15,600
+10,000 vol
$1.56 each
1,050,000
Filed 2019-08-30 11:04
Tx date 2019-08-28
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$14,800
+10,000 vol
$1.48 each
1,040,000
Filed 2019-08-30 11:01
Tx date 2019-08-28
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$14,200
+10,000 vol
$1.42 each
1,030,000
Filed 2019-08-27 12:02
Tx date 2019-08-23
$KHRN
Khiron Life Sciences Corp.
Kaufman, Wendy
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+300,000 vol
300,000
Filed 2019-08-27 11:56
Tx date 2019-07-02
$KHRN
Khiron Life Sciences Corp.
Kaufman, Wendy
5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-07-29 15:39
Tx date 2019-05-31
$KHRN
Khiron Life Sciences Corp.
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+2,000,000 vol
2,000,000
Filed 2019-07-29 15:34
Tx date 2018-07-17
$KHRN
Khiron Life Sciences Corp.
Fox Quesada, Vicente
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-07-26 13:54
Tx date 2019-05-31
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
56 - Grant of rights

+400,000 vol
400,000
Filed 2019-07-26 13:46
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
Filed 2019-07-12 11:54
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Graciela Martinelli (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report
20,325
Filed 2019-06-26 21:05
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2019-06-26 20:56
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Silveira, Maximiliano Perez
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
349,641
Filed 2019-06-26 20:54
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Silveira, Maximiliano Perez
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
25,000
Filed 2019-06-26 20:33
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Beramendi, Marco Algorta
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
25,000
Filed 2019-06-26 20:30
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Beramendi, Marco Algorta
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
495,397
Filed 2019-06-26 16:14
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Loinaz D'Isabella, Agustina Nathalia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
495,397
Filed 2019-06-26 16:10
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Loinaz D'Isabella, Agustina Nathalia
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
25,000
Filed 2019-06-26 15:20
Tx date 2019-05-31
$KHRN
Khiron Life Sciences Corp.
Beck, Michael Paul
4 - Director of Issuer
Direct Ownership
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2019-06-21 15:33
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$2,012,500
+1,250,000 vol
$1.61 each
1,250,000
Filed 2019-06-21 15:32
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Mimran, Joseph
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-21 15:18
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Beck, Michael Paul
4 - Director of Issuer
Holder: Angstrom Capital Ltd. (Indirect Ownership)
Common Shares
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
$1,449,000
+900,000 vol
$1.61 each
900,000
Filed 2019-06-21 15:16
Tx date 2019-05-31
$KHRN
Khiron Life Sciences Corp.
Beck, Michael Paul
4 - Director of Issuer
Holder: Angstrom Capital Ltd. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-06-20 14:31
Tx date 2019-06-19
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market
$48,000
+20,000 vol
$2.40 each
1,020,000
Filed 2019-06-20 11:31
Tx date 2019-06-18
$KHRN
Khiron Life Sciences Corp.
Maduri, Livia Margarita
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
300,000
Filed 2019-04-24 09:25
Tx date 2018-10-09
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$60,000
+50,000 vol
$1.20 each
548,000
Filed 2019-04-24 09:24
Tx date 2018-10-05
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants
$90,000
+75,000 vol
$1.20 each
498,000
Filed 2019-04-24 09:21
Tx date 2018-10-09
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-50,000 vol
0
Filed 2019-04-24 09:20
Tx date 2018-10-05
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants

-75,000 vol
50,000
Filed 2019-04-22 15:50
Tx date 2018-06-26
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Holder: Napperville Corp. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2019-02-28
Tx date 2019-02-25
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$220,000
+100,000 vol
$2.20 each
1,431,889
Filed 2018-12-10
Tx date 2018-12-05
$KHRN
Khiron Life Sciences Corp.
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$11,800
+10,000 vol
$1.18 each
719,500
Filed 2018-12-07
Tx date 2018-12-05
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$6,150
+5,000 vol
$1.23 each
1,316,889
Filed 2018-12-07
Tx date 2018-12-05
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$18,600
+15,000 vol
$1.24 each
1,331,889
Filed 2018-11-05
Tx date 2018-09-07
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$90,720
+100,800 vol
$0.90 each
Filed 2018-11-05
Tx date 2018-09-12
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$800,000.10
+888,889 vol
$0.90 each
1,311,889
Filed 2018-11-05
Tx date 2018-10-02
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,656
-1,600 vol
$1.66 each
1,300,089
Filed 2018-11-05
Tx date 2018-10-05
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+90,000 vol
Filed 2018-11-05
Tx date 2018-09-07
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$90,720
+100,800 vol
$0.90 each
Filed 2018-11-05
Tx date 2018-10-02
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-5,280
-3,200 vol
$1.65 each
1,296,889
Filed 2018-11-05
Tx date 2018-10-05
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+90,000 vol
Filed 2018-11-05
Tx date 2018-09-07
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$100,800
+112,000 vol
$0.90 each
423,000
Filed 2018-11-05
Tx date 2018-10-05
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+75,000 vol
125,000
Filed 2018-11-05
Tx date 2018-10-02
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-16,728
-10,200 vol
$1.64 each
1,301,689
Filed 2018-11-05
Tx date 2018-10-05
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+60,000 vol
Filed 2018-11-05
Tx date 2018-06-26
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-11-05
Tx date 2018-10-05
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+50,000 vol
50,000
Filed 2018-11-05
Tx date 2018-10-02
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$24,600
+15,000 vol
$1.64 each
1,311,889
Filed 2018-11-05
Tx date 2018-10-05
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+60,000 vol
Filed 2018-09-14
Tx date 2018-09-12
$KHRN
Khiron Life Sciences Corp.
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
15 - Acquisition or disposition under a prospectus
$41,040
+45,600 vol
$0.90 each
947,450
Filed 2018-09-11
Tx date 2018-08-28
$KHRN
Khiron Life Sciences Corp.
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately

+35,714 vol
35,714
Filed 2018-09-11
Tx date 2018-08-28
$KHRN
Khiron Life Sciences Corp.
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
Options
11 - Acquisition or disposition carried out privately

+200,000 vol
200,000
Filed 2018-09-11
Tx date 2018-05-28
$KHRN
Khiron Life Sciences Corp.
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-11
Tx date 2018-05-28
$KHRN
Khiron Life Sciences Corp.
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,232,143
Filed 2018-09-11
Tx date 2018-05-28
$KHRN
Khiron Life Sciences Corp.
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-11
Tx date 2018-05-28
$KHRN
Khiron Life Sciences Corp.
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-05
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-05
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Monaghan, Mark
4 - Director of Issuer
Holder: Dalvay Capital Corp. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
1,850,000
Filed 2018-09-05
Tx date 2018-06-26
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2018-09-05
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
35,715
Filed 2018-09-05
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
35,714
Filed 2018-09-05
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-05
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-05
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-05
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Monaghan, Mark
4 - Director of Issuer
Holder: Dalvay Capital Corp. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-05
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-05
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
35,715
Filed 2018-09-05
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
709,500
Filed 2018-09-05
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-04
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
4,015,477
Filed 2018-09-04
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
4,015,476
Filed 2018-09-04
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
4,015,476
Filed 2018-09-04
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-04
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-09-04
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2018-08-20
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
35,357
Filed 2018-08-20
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
3,975,322
Filed 2018-08-20
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2018-08-20
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
100,000
Filed 2018-08-20
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
15,000
Filed 2018-08-20
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Galofre, Andres
6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
35,714
Filed 2018-08-20
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
3,975,322
Filed 2018-08-20
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2018-08-20
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Holder: Cannaversiones S.A.S. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
35,357
Filed 2018-08-20
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Monaghan, Mark
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,559,500
Filed 2018-08-16
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
35,357
Filed 2018-08-16
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
51,758
Filed 2018-08-16
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Yanez, Alvaro Josue
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2018-08-16
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Holder: Cannainversiones S.A.S. (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
3,975,322
Filed 2018-08-16
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Torres, Andres Eduardo
6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
119,045
Filed 2018-08-15
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Simeon, Peter Emmanouil
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
310,000
Filed 2018-08-15
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Simeon, Peter Emmanouil
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2018-07-23
Tx date 2018-06-26
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
281,000
Filed 2018-07-23
Tx date 2018-07-17
$KHRN
Khiron Life Sciences Corp.
Naprawa, Chris
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$32,481
+30,000 vol
$1.08 each
311,000
Filed 2018-07-20
Tx date 2018-07-17
$KHRN
Khiron Life Sciences Corp.
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$18,725
+17,500 vol
$1.07 each
901,850
Filed 2018-05-31
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Cannainversiones S.A.S.
3 - 10% Security Holder of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
12,046,429
Filed 2018-05-31
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Torres, Alvaro Francisco
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2018-05-31
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
864,350
Filed 2018-05-31
Tx date 2018-05-16
$KHRN
Khiron Life Sciences Corp.
Cannainversiones S.A.S.
3 - 10% Security Holder of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
107,143
Filed 2018-05-31
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$22,200
+20,000 vol
$1.11 each
884,350
Filed 2018-05-31
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
35,715
Filed 2018-05-31
Tx date 2018-05-24
$KHRN
Khiron Life Sciences Corp.
Collins, Darren George
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
200,000
Filed 2018-05-28
Tx date 2018-05-28
$KHRN
Khiron Life Sciences Corp.
Himmel, Sidney Samuel
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
2,321,430